Foundation One has announced that The Food and Drug Administration (FDA) has approved a “breakthrough device” that has the potential to match cancer patients with more accurate individualized treatment regiments with just one test. This test will push the boundaries of personalized medicine as it might allow us to choose better treatments that are most likely to be effective for specific types of cancer — and to make those decisions sooner.
This blog is focused on providing people who have been diagnosed with either a rare cancer or with more than one cancer a place where they can keep up with information, research and discoveries that could impact their lives in the near term.
Rare cancers and multiple cancers have been ignored for too long. Research dollars are far too limited.
Please let us know if you hear of anything new that needs to be shared with our community.
